Search results
Author(s):
Dominik Linz
,
Sander Verheule
,
Aaron Isaacs
,
et al
Added:
2 years ago
Author(s):
Axel Brandes
,
Marcelle D Smit
,
Bao Oanh Nguyen
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most common clinical arrhythmia worldwide and is expected to increase in the coming decades.1,2 It currently affects up to 3 % of Western populations aged 20 years or older, and the number of affected individuals in the EU will increase from about 7 million to almost 13 million by 2030.3–5 This growing epidemic is not only caused by the natural ageing of the…
View more
Author(s):
Michael G Fradley
Added:
1 year ago
In this video, we invited Dr Michael Fradley, Medical Director of the Thalheimer Center for Cardio-oncology at Penn Medicine, to discuss the topic of arrhythmias in cancer patients. Dr Fradley is an active cardiologist specialising in cardio-oncology and electrophysiology.
Discussion Points:
1. What are the main cancer treatments that cause this problem?
2. Are there risk factors that predispose…
View more
Author(s):
Wern Yew Ding
Added:
2 years ago
Management of Cardiovascular Implantable Electronic Devices Infections in High-Risk Patients
Author(s):
Charles Kennergren
Added:
3 years ago
Article
Author(s):
Agnieszka Kotalczyk
,
Gregory YH Lip
,
Hugh Calkins
Added:
2 years ago
Author(s):
Juan Sieira
,
Pedro Brugada
Added:
3 years ago
Brugada syndrome (BS) is an inherited disease characterised by coved-type ST-segment elevation in the right precordial leads (V1–V3) and an increased risk of sudden cardiac death (SCD) in the absence of structural heart disease.1
It typically affects otherwise healthy individuals in their forties.2 SCD is the most dramatic presentation, but many patients are asymptomatic at the time of diagnosis…
View more
Author(s):
Khaldoun G Tarakji
,
Christopher R Ellis
,
Pascal Defaye
,
et al
Added:
3 years ago
Over the last few decades an increasing body of evidence has supported the role of cardiovascular implantable electronic devices (CIEDs) including permanent pacemakers (PPMs), implantable cardioverter-defibrillators (ICDs) and cardiac resynchronisation therapy (CRT-D [with defibrillator] and CRT-P [without defibrillator]) in improving quality of life and survival.1 In addition, there has been a…
View more
Author(s):
Yaacoub Chahine
,
Matthew J Magoon
,
Bahetihazi Maidu
,
et al
Added:
1 year ago
Author(s):
Nicolas Meneveau
,
Andrew SP Sharp
,
Adriaan Kraaijeveld
Added:
5 years ago
Acoustic pulse thrombolysis treatment for pulmonary embolism patients: rationale, experience and data
Part 1 - Prof Nicolas Meneveau
Part 2 - Prof Andrew Sharp
Part 3 - Dr Adriaan Kraaijeveld
View more